International research on arsenic contamination and health

Journal of Health, Population and Nutrition

Volumn 24, Issue 2, 2006, Pages 123-128

  Rahman, Mahfuzar ^a  

^a ICDDRB Public Health Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC DERIVATIVE; DRINKING WATER;

AIR POLLUTION; AMEBIASIS; ARSENIC POISONING; ASTHMA; BIRTH DEFECT; BLACKFOOT DISEASE; BLADDER CANCER; CANCER RISK; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DERMATITIS; DRUG FORMULATION; EDITORIAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MANAGEMENT; EPILEPSY; HEALTH HAZARD; HUMAN; HYPERTENSION; LUNG CANCER; MELANOSIS; MOBILE PHONE; POLLUTION; PROMYELOCYTIC LEUKEMIA; PSORIASIS; REPEATED DRUG DOSE; SKIN CANCER; SKIN DEFECT; TRYPANOSOMIASIS; UNSPECIFIED SIDE EFFECT; WATER CONTAMINATION;

ARSENIC POISONING; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; ENVIRONMENTAL POLLUTION; HEALTH STATUS; HUMANS; POPULATION SURVEILLANCE; RESEARCH; SKIN DISEASES; SKIN NEOPLASMS; VASCULAR DISEASES; WORLD HEALTH;

EID: 33846505437     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (76)

1. Buchanan WD. Toxicity of arsenic compounds. Amsterdam: Elsevier, 1962. 155 p. (Elsevier monographs on toxic agents).
2. Squibb KS, Fowler BA. The toxicity of arsenic and its compounds. In: Fowler BA, editor. Biological and environmental effects of arsenic. Amsterdam: Elsevier, 1983:233-69.
3. World Health Organization. Arsenic. Geneva: World Health Organization, 1981. 174 p. (Environmental health criteria no. 18).
4. International Agency for Research on Cancer. Some drinking-water disinfectants and contaminants, including arsenic. Lyon: International Agency for Research on Cancer, 2004:41-267. (IARC monographs on the evaluation of carcinogenic risks to humans, v. 84).
5. U.S. National Research Council. Arsenic in drinking water: 2001 update. Washington, DC: National Academy Press, 2001. 244 p.
6. International Agency for Research on Cancer. On the evaluation of the carcinogenic risk of chemicals to humans: some metals and metallic compounds, v. 23. Lyon: International Agency for Research on Cancer, 1980:39-141.
7. Mehrag AA. Venomous earth: how arsenic caused the world's worst mass poisoning. Hampshire; Mcmillan, 2005. 192 p.
8. Kerr HD, Saryan LA. Arsenic content of homeopathic medicines. Clin Tox 1986;24:451-9.
9. Dunbabin DW, Tallis GA, Popplewell PY, Lee RA. Lead poisoning from Indian herbal medicine (Ayurveda). Med J Aust 1992;157:835-6.
10. Mitchell-Heggs CA, Conway M, Cassar J. Herbal medicine as a cause of combined lead and arsenic poisoning. Hum Exp Toxicol 1990;9:195-6.
11. Tay CH, Seah CS. Arsenic poisoning from anti-asthmatic herbal preparations. Med J Aust 1975;2:424-8.
12. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998;339:1341-8.
13. Douer D, Tallman MS. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 2005;23:2396-410.
14. Leslie AC, Smith H. Napoleon Bonaparte's exposure to arsenic during 1816. Arch Toxicol 1978;41:163-7.
15. Tibbetts J. Water world 2000. Environ Health Perspect 2000;108:69-73.
16. Knobeloch LM, Zierold KM, Anderson HA, Farrar A. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley. J Health Popul Nutr 2006;24:206-13.
17. Concha G, Nermell B, Vahter M. Spatial and temporal variations in arsenic exposure via drinking-water in northern Argentina. J Health Popul Nutr 2006;24 (In press).
18. Sancha AM. Review of coagulation technology for removal of arsenic: case of Chile. J Health Popul Nutr 2006;24 (In press).
19. Ferreccio C, Sancha AM. Arsenic exposure and its impact on health in Chile. J Health Popul Nutr 2006;24:164-75.
20. Ahamed S, Sengupta MK, Mukherjee SC, Pati S, Mukherjee A, Rahman MM et al. An eight-year study report on arsenic contamination in groundwater and health effects in Eruani village, Bangladesh and an approach for its mitigation. J Health Popul Nutr 2006;24:129-41.
21. Li D, An D, Zhou Y, Liu J, Waalkes MP. Current status and prevention strategy for coal-arsenic poisoning in Guizhou, China. J Health Popul Nutr 2006;24 (In press).
22. Sun G, Li X, Pi J, Sun Y, Li B, Jin Y et al. Current research problems of chronic arsenicosis in China. J Health Popul Nutr 2006;24:176-81.
23. Guo X, Liu Z, Huang C, You L. Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia. J Health Popul Nutr 2006;24:214-20.
24. Maharjan M, Shrestha RR, Ahmad SA, Watanabe C, Ohtsuka R. Prevalence of arsenicosis in terai, Nepal. J Health Popul Nutr 2006;24:246-52.
25. McDonald C, Hoque R, Huda N, Cherry N. Prevalence of arsenic-related skin lesions in 53 widely-scattered villages of Bangladesh: an ecological survey. J Health Popul Nutr 2006;24:228-35.
26. Tseng WP, Chen WY, Sung JL, Chen JS. A clinical study of blackfoot diseases in Taiwan, an endemic peripheral vascular disease. Mem Coll Med Natl Taiwan 1961;7:1-17.
27. Blackwell RQ, Yang TH, Ali I. Preliminary report on arsenic level in water and food from endemic blackfoot area. J Formos Med Assoc 1961;60:1139-40.
28. Saha KC. Melanokeratosis from arsenic contaminated tubewell water. Indian J Dermatol 1984;29:37-46.
29. Saha KC. Arsenicosis in West Bengal. Environmental problems. Kolkata: Sadana Prokashani, 2002:1-175.
30. Smith AH, Lingas EO, Rahman M. Contamination of drinking water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ 2000;78:1093-103.
31. Ng JC, Wang JP, Zheng B, Zhai C, Maddalena R, Liu F, Moore MR. Urinary porphyrins as biomarkers for arsenic exposure among susceptible populations in Guizhou province, China. Toxicol Appl Pharmacol 2005;206:176-84.
32. Meza MM, Kopplin MJ, Burgess JL, Gandolfi AJ. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico. Environ Res 2004;96:119-26.
33. Stanger G, Truong TV, Ngoc KS, Luyen TV, Thanh TT. Arsenic in groundwater of the Lower Mekong. Environ Geochem Health 2005;27:341-57.
34. Amonoo-Neizer EH, Amekor EM. Determination of total arsenic in environmental samples from Kumasi and Obuasi, Ghana. Environ Health Perspect 1993;101:46-9.
35. Berg M, Tran HC, Nguyen TC, Pham HV, Schertenleib R, Giger W. Arsenic contamination of groundwater and drinking water in Vietnam: a human health threat. Environ Sci Technol 2001;35:2621-6.
36. Foy HM, Tarmapai S, Eamchan P, Metdilogkul O. Chronic arsenic poisoning from well water in a mining area in Thailand. Asia Pac J Public Health 1992;6:150-2.
37. Mukherjee A, Sengupta MK, Hossain MA, Ahamed S, Das B, Nayak B et al. Arsenic contamination in groundwater: a global perspective with emphasis on the Asian scenario. J Health Popul Nutr 2006;24:142-63.
38. Hasnat AH, Rahman M. Environmental pollution and skin involvement pattern of chronic arsenicosis in Bangladesh. J Occup Health 1999;41:207-8.
39. Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D et al. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 1998;27:871-7.
40. Hutchinson J. Arsenic cancer. Br Med J 1887;2: 1280-1.
41. Neubauer O. Arsenical cancer: a review. Br J Cancer 1947;1:192-251.
42. Tseng WP. Effects and dose response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 1977;19:109-19.
43. Hsueh YM, Cheng GS, Wu MM, Yu HS, Kuo TL, Chen CJ. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer 1995;71:109-14.
44. Cabrera HN, Gomez ML. Skin cancer induced by arsenic in the water. J Cutan Med Surg 2003;7:106-11.
45. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 2001;153:559-65.
46. Pesch B, Ranft U, Jakubis P, Nieuwenhuijsen MJ, Hergemoller A et al. Environmental arsenic exposure from a coal-burning power plant as a potential risk factor for nonmelanoma skin carcinoma: results from a case-control study in the district of Prievidza, Slovakia. Am J Epidemiol 2002;155:798-809.
47. Dorfner B, Baum C, Voigtlander V. [Multiple superficial basal cell carcinomas following chronic ingestion of sodium hydrogen carbonate containing arsenic]. Hautarzt 2002;53:542-5.
48. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL. Toenail arsenic content and cutaneous melanoma in Iowa. Am J Epidemiol 2004;160:679-87.
49. Arguello RA, Conget DD, Tello EE. Cancer and endemic arsenism in the Cordoba Region. Rev Argent Dermatol 1939;22:461-87.
50. Smith AH, Lopipero PA, Bates MN, Steinmaus CM. Public health. Arsenic epidemiology and drinking water standards. Science 2002;296:2145-6.
51. Chen CJ, Hseuh YM, Lai MS, Shyu MP, Chen SY, Wu MM et al. Increased prevalence of hypertension and long term arsenic exposure. Hypertension 1995;25:53-60.
52. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 1997;28:1717-23.
53. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension 1999;33:74-8.
54. Tseng WP: Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 1989;40:547-58.
55. Tseng CH, Chong CK, Chen CJ, Tai TY. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic village in Taiwan. Atherosclerosis 1996;120:125-33.
56. Hsueh YM, Wu WL, Huang YL, Chiou HY, Tseng CH, Chen CJ. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 1998 Dec;141:249-57.
57. Chen CJ. Blackfoot disease. Lancet 1990;336:442.
58. Chen Y, Hakim ME, Parvez F, Islam T, Rahman AM, Ahsan H. Arsenic exposure from drinking-water and carotid artery intima-medial thickness in healthy young adults in Bangladesh (short report). J Health Popul Nutr 2006;24:253-7.
59. Ahmad SA, Khatun F, Sayed MHSU, Khan MH, Aziz MR, Hossain MZ et al. Electrocardiographic abnormalities among arsenic-exposed persons through groundwater in Bangladesh. J Health Popul Nutr 2006;24:221-7.
60. Tseng H-P, Wang Y-H, Wu M-M, The H-W, Chiou H-Y, Chen C-J. Association between chronic exposure to arsenic and slow nerve conduction velocity among adolescents in Taiwan. J Health Popul Nutr 2006;24:182-9.
61. Kwok RK, Kaufmann RB, Jakariya M. Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme. J Health Popul Nutr 2006;24:190-205.
62. Hopenhayn-Rich C, Browning SR, Hertz-Picciotto I, Ferreccio C, Peralta C, Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect 2000;108:667-73.
63. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C, Gibb H, Hertz-Picciotto I. Arsenic exposure from drinking water and birth weight. Epidemiology 2003;14:593-602.
64. Milton AH, Smith W, Rahman B, Hasan Z, Kulsum U, Dear K et al. Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 2005;16:82-6.
65. Ahmad SA, Sayed MH, Barua S, Khan Mn, Faruquee MH, Jalil A et al. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect 2001;109:629-31.
66. Borzsonyi M, Bereczky A, Rudnai P, Csanady M, Horvath A. Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Arch Toxicol 1992;66:77-8.
67. Yang CY, Chang CC, Tsai SS, Chuang HY, Ho CK, Wu TN. Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan. Environ Res 2003;91:29-34.
68. Savarimuthu X, Smith MMH, Yuan Y, von Ehrenstein O, Ghosh N, Guha Mazumder DN et al. Seasonal variation of arsenic concentrations in tubewells in West Bengal, India. J Health Popul Nutr 2006;24 (In press).
69. Steinmaus CM, Yuan Y, Smith AH. The temporal stability of arsenic concentrations in well water in Western Nevada. Environ Res 2005;99:164-8.
70. Cheng Z, van Geen A, Seddique AA, Ahmed KM. Limited temporal variability of arsenic concentrations in 20 wells monitored for 3 years in Araihazar, Bangladesh. Environ Sci Technol 2005;39:4759-66.
71. Huq SMI, Joardar JC, Parvin S, Correll R, Naidu R. Arsenic contamination in food chain: transfer of arsenic into food materials through groundwater irrigation. J Health Popul Nutr 2006;24 (In press).
72. Joya SA, Mostofa G, Yousuf J, Islam A, Elahi A, Mahiuddin G et al. One solution to the arsenic problem: a return to surface (improved dug) wells. J Health Popul Nutr 2006;24 (In press).
73. Islam MF, Johnston RB. Household pasteurization of drinking-water: the chulli water-treatment system. J Health Popul Nutr 2006;24 (In press).
74. Howard G, Ahmed MF, Shamsuddin AJ, Mahmud SG, Deere D. Risk assessment of arsenic mitigation options in Bangladesh. J Health Popul Nutr 2006;24 (In press).
75. van Geen A, Trevisani M, Immel J, Jakariya M, Osman N, Cheng Z. Targeting low-arsenic groundwater with mobile-phone technology in Araihazar, Bangladesh. J Health Popul Nutr 2006;24 (In press).
76. Nordstrom DK. Public health. Worldwide occurrences of arsenic in ground water. Science 2002;296:2143-5.